Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Neuroepithelial Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Neuroepithelial, Perineurial, and Schwann Cell Neoplasm
Neuroepithelial Neoplasm

Cancer Family

Neuroepithelial Neoplasm

CI-CAN-00000287Explore in graph →

Non-malignant811 active trials6 approved drugs154 evidence items

NCIt: C3787
OncoTree: PRNET
UMLS CUI: C0206715
MeSH: D018302

Overview
Statistics
Survival
Genomics26
Variants & evidence154
Drugs34
Trials2934
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (109)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–25 of 109 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

MGMT gene silencing and benefit from temozolomide in glioblastoma.
· N Engl J Med · 2005 · PMID 15758010 · validated civic_curation pubmed
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
· N Engl J Med · 2023 · PMID 37272516 · validated civic_curation pubmed
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
· Nat Med · 2024 · PMID 37978284 · validated civic_curation pubmed
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma.
· J Clin Oncol · 2023 · PMID 36375115 · validated civic_curation pubmed
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
· J Clin Oncol · 2024 · PMID 38335473 · validated civic_curation pubmed
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
· Acta Neuropathol · 2016 · PMID 27157931 · validated civic_curation pubmed
IDH1 and IDH2 mutations in gliomas.
· N Engl J Med · 2009 · PMID 19228619 · validated civic_curation pubmed
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.

Showing 1–25 of 109 publications

← Previous
1
2
…
5
Next →

· Nat Genet · 2013 · PMID 23817572 · validated civic_curation pubmed

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

· N Engl J Med · 2000 · PMID 11070098 · validated civic_curation pubmed

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

· J Clin Oncol · 2009 · PMID 19901104 · validated civic_curation pubmed

TERT promoter mutations in primary and secondary glioblastomas.

· Acta Neuropathol · 2013 · PMID 23955565 · validated civic_curation pubmed

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

· N Engl J Med · 2005 · PMID 16282176 · validated civic_curation pubmed

LRP1B deletion is associated with poor outcome for glioblastoma patients.

· J Neurol Sci · 2015 · PMID 26428308 · validated civic_curation pubmed

Pediatric low-grade gliomas can be molecularly stratified for risk.

· Acta Neuropathol · 2018 · PMID 29948154 · validated civic_curation pubmed

BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma.

· Clin Cancer Res · 2011 · PMID 21610142 · validated civic_curation pubmed

Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.

· Nat Genet · 2013 · PMID 23583981 · validated civic_curation pubmed

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.

· Cancer Res · 2008 · PMID 18974108 · validated civic_curation pubmed

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

· Cell · 2016 · PMID 26919435 · validated civic_curation pubmed

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.

· Cancer Cell · 2015 · PMID 25965575 · validated civic_curation pubmed

MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.

· Nat Genet · 2016 · PMID 26829751 · validated civic_curation pubmed

A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration.

· Acta Neuropathol · 2019 · PMID 31595312 · validated civic_curation pubmed

Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

· Acta Neuropathol · 2020 · PMID 31563982 · validated civic_curation pubmed

Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.

· Proc Natl Acad Sci U S A · 2013 · PMID 23633565 · validated civic_curation pubmed

Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features.

· Brain Pathol · 2019 · PMID 30246434 · validated civic_curation pubmed

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).

· Neuro Oncol · 2022 · PMID 35395680 · validated civic_curation pubmed